311 related articles for article (PubMed ID: 27996943)
1. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain.
Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A
J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943
[TBL] [Abstract][Full Text] [Related]
2. Venom immunotherapy in patients with allergic reactions to insect stings.
Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
[TBL] [Abstract][Full Text] [Related]
3. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
4. When can immunotherapy for insect sting allergy be stopped?
Müller UR; Ring J
J Allergy Clin Immunol Pract; 2015; 3(3):324-8; quiz 329-30. PubMed ID: 25956311
[TBL] [Abstract][Full Text] [Related]
5. Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts.
Brunetto S; Gammeri L; Buta F; Gangemi S; Ricciardi L
Allergy Asthma Proc; 2024 May; 45(3):195-200. PubMed ID: 38755779
[No Abstract] [Full Text] [Related]
6. Key Issues in Hymenoptera Venom Allergy: An Update.
Alfaya Arias T; Soriano Gómis V; Soto Mera T; Vega Castro A; Vega Gutiérrez JM; Alonso Llamazares A; Antolín Amérigo D; Carballada Gonzalez FJ; Dominguez Noche C; Gutierrez Fernandez D; Marques Amat L; Martinez Arcediano A; Martinez San Ireneo M; Moreno Ancillo A; Puente Crespo Y; Ruiz Leon B; Sánchez Morillas L;
J Investig Allergol Clin Immunol; 2017; 27(1):19-31. PubMed ID: 28211342
[TBL] [Abstract][Full Text] [Related]
7. A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.
Kalogeromitros D; Makris M; Koti I; Chliva C; Mellios A; Avgerinou G; Theoharides TC
Allergol Immunopathol (Madr); 2010; 38(2):69-73. PubMed ID: 19853357
[TBL] [Abstract][Full Text] [Related]
8. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
[TBL] [Abstract][Full Text] [Related]
9. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.
Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B;
J Allergy Clin Immunol; 2010 Jul; 126(1):105-11.e5. PubMed ID: 20542320
[TBL] [Abstract][Full Text] [Related]
10. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
11. Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.
Lange J; Cichocka-Jarosz E; Marczak H; Krauze A; Tarczoń I; Świebocka E; Lis G; Brzyski P; Nowak-Węgrzyn A
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):225-9. PubMed ID: 26945496
[TBL] [Abstract][Full Text] [Related]
12. Stinging insect allergy: state of the art 2015.
Tankersley MS; Ledford DK
J Allergy Clin Immunol Pract; 2015; 3(3):315-22; quiz 323. PubMed ID: 25956310
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan.
Hirata H; Asakura T; Arima M; Cheng G; Honda K; Fukushima F; Yamaguchi B; Yoshida N; Fukuda T
Asian Pac J Allergy Immunol; 2003 Jun; 21(2):89-94. PubMed ID: 14629126
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy against hymenoptera venom: report of ten patients].
Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Hymenoptera venom allergy.
Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
[TBL] [Abstract][Full Text] [Related]
16. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy.
Cabrera CM; Urra JM; Alfaya T; Roca Fde L; Feo-Brito F
Mol Immunol; 2014 Nov; 62(1):178-85. PubMed ID: 25004111
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Hymenoptera venom allergy: an update.
Pesek RD; Lockey RF
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):340-6. PubMed ID: 24887986
[TBL] [Abstract][Full Text] [Related]
18. Hymenoptera venom immunotherapy and field stings.
Lang R; Hawranek T
J Investig Allergol Clin Immunol; 2006; 16(4):224-31. PubMed ID: 16889279
[TBL] [Abstract][Full Text] [Related]
19. Hymenoptera venom allergy in humans.
Cichocka-Jarosz E
Folia Med Cracov; 2012; 52(3-4):43-60. PubMed ID: 24852686
[TBL] [Abstract][Full Text] [Related]
20. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]